Included Health filed its S-1 for an IPO that never happened. Its CEO said the company went heads-down to reach profitability ...

The IPO trend remains robust in 2025, driven by strong retail investor interest and a shift from FPIs to the primary market.

By Rishika Sadam HYDERABAD (Reuters) -Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its ...

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

The amount raised via IPOs almost tripled from ₹53,023 crore to ₹1.53 trillion in the same period. The mainboard platform ...

Private equity-backed Infinity Natural Resources raised $265 million on Thursday in its initial public offering in the U.S., the latest first-time share sale by an energy company in New York in recent ...

Shares of liquefied natural gas exporter Venture Global finished Friday's first day of trading below their initial public ...

Analysts say outlook is good after uneven trading start; leaders Sabel and Pender see windfall from stock listing ...

The Gujarat-based company targets to mobilise Rs 14.6 crore via solely fresh issue of 29.19 lakh shares. The offer will close ...

Venture Global, a producer of liquified natural gas, made its stock market debut on Friday as President Trump plans to boost ...